Organogenesis Holdings Q3 EPS $(0.12) Beats $(0.13) Estimate, Sales $64.265M Beat $62.95M Estimate

Organogenesis Holdings (NASDAQ:ORGO) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7.69 percent. The company reported quarterly sales of $64.265 million which

Benzinga · 11/12/2019 21:09

Organogenesis Holdings (NASDAQ:ORGO) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7.69 percent. The company reported quarterly sales of $64.265 million which beat the analyst consensus estimate of $62.95 million by 2.09 percent.